Literature DB >> 19524005

Increased number of CD16(+)CD56(dim) NK cells in peripheral blood mononuclear cells after allogeneic cord blood transplantation.

Junji Tanaka1, Junichi Sugita, Shinsuke Asanuma, Kotaro Arita, Yusuke Shono, Misato Kikutchi, Souichi Shiratori, Kentaro Wakasa, Atsushi Yasumoto, Akio Shigematu, Takeshi Kondo, Takahiko Kobayashi, Masahiro Asaka, Masahiro Imamura.   

Abstract

In the present study, we investigated subpopulations of natural killer (NK) cells and the expression of stimulatory and inhibitory NK receptors after adult blood and bone marrow transplantation (BBMT) and cord blood transplantation (CBT). There were significant increases in CD16(+)CD56(dim) cell proportion and in absolute number in peripheral blood mononuclear cells (PBMC) during a period of 4-9 months after CBT compared with these in normal PBMC, cord blood (CB), and in PBMC after BBMT. Also, increased numbers of CD16(+)CD56(dim) NK cells were sustained in some patients until 4 years after CBT. This CD16(+)CD56(dim) cell subset after CBT exhibited decreased expression of NKG2A compared with that in CB and increased expression of NKG2C. Purified CD16(+)CD56(dim) cells from patients 8-9 months after CBT exhibited significantly higher levels of cytolytic activity against K562 than did purified CD16(+)CD56(bright) cells and also whole PBMC. The CD16(+)CD56(dim) cell subset with a high level of cytolytic activity significantly increased after CBT, and these cells may be responsible for NK cell-mediated immunity after CBT.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19524005     DOI: 10.1016/j.humimm.2009.06.002

Source DB:  PubMed          Journal:  Hum Immunol        ISSN: 0198-8859            Impact factor:   2.850


  7 in total

1.  Human umbilical cord blood-derived stromal cells, a new resource in the suppression of acute graft-versus-host disease in haploidentical stem cell transplantation in sublethally irradiated mice.

Authors:  Cheng Zhang; Xing-Hua Chen; Xi Zhang; Lei Gao; Pei-Yan Kong; Xian-gui Peng; Xue Liang; Li Gao; Yi Gong; Qing-Yu Wang
Journal:  J Biol Chem       Date:  2011-02-24       Impact factor: 5.157

2.  Immune recovery in adult patients after myeloablative dual umbilical cord blood, matched sibling, and matched unrelated donor hematopoietic cell transplantation.

Authors:  Junya Kanda; Lun-Wei Chiou; Paul Szabolcs; Gregory D Sempowski; David A Rizzieri; Gwynn D Long; Keith M Sullivan; Cristina Gasparetto; John P Chute; Ashley Morris; Jacalyn McPherson; Jeffrey Hale; John Andrew Livingston; Gloria Broadwater; Donna Niedzwiecki; Nelson J Chao; Mitchell E Horwitz
Journal:  Biol Blood Marrow Transplant       Date:  2012-06-12       Impact factor: 5.742

3.  Rapid NK cell differentiation in a population with near-universal human cytomegalovirus infection is attenuated by NKG2C deletions.

Authors:  Martin R Goodier; Matthew J White; Alansana Darboe; Carolyn M Nielsen; Adriana Goncalves; Christian Bottomley; Sophie E Moore; Eleanor M Riley
Journal:  Blood       Date:  2014-08-22       Impact factor: 22.113

4.  T-Bet Mediated Anti-Neoplastic Effects of Dendritic Cell-Cytokine Induced Killer Cells in vitro.

Authors:  Liu Miao; Jin Run-Ming; Jiang Yi
Journal:  Iran J Pediatr       Date:  2012-03       Impact factor: 0.364

Review 5.  Improving engraftment and immune reconstitution in umbilical cord blood transplantation.

Authors:  Robert Danby; Vanderson Rocha
Journal:  Front Immunol       Date:  2014-02-24       Impact factor: 7.561

6.  Up-regulation of activating and inhibitory NKG2 receptors in allogeneic and autologous hematopoietic stem cell grafts.

Authors:  Alessandra Picardi; Andrea Mengarelli; Mirella Marino; Enzo Gallo; Maria Benevolo; Edoardo Pescarmona; Roberta Cocco; Rocco Fraioli; Elisa Tremante; Maria Concetta Petti; Paolo De Fabritiis; Patrizio Giacomini
Journal:  J Exp Clin Cancer Res       Date:  2015-09-11

7.  Effects of KIR ligand incompatibility on clinical outcomes of umbilical cord blood transplantation without ATG for acute leukemia in complete remission.

Authors:  J Tanaka; Y Morishima; Y Takahashi; T Yabe; K Oba; S Takahashi; S Taniguchi; H Ogawa; Y Onishi; K Miyamura; H Kanamori; N Aotsuka; K Kato; S Kato; Y Atsuta; Y Kanda
Journal:  Blood Cancer J       Date:  2013-11-29       Impact factor: 11.037

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.